The Delaware companies entered a Development and License Agreement on September 23, 2026 covering US distribution rights, with terms disclosed in a September 29 SEC filing.
The company cited an adverse Delaware court decision on CINVANTI patents and a paused sales force expansion as reasons it can no longer forecast the year.
